| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
66,405 |
64,270 |
$4.94M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
48,291 |
34,757 |
$2.36M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
62,455 |
60,210 |
$1.97M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
62,434 |
60,208 |
$1.96M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
62,709 |
60,793 |
$1.55M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,171 |
10,092 |
$1.53M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17,651 |
17,500 |
$1.32M |
| 84443 |
Thyroid stimulating hormone (TSH) |
72,067 |
71,360 |
$1.05M |
| 80053 |
Comprehensive metabolic panel |
88,467 |
86,095 |
$814K |
| 87480 |
|
45,386 |
43,875 |
$798K |
| 87510 |
|
44,607 |
43,140 |
$784K |
| 87660 |
|
44,560 |
43,094 |
$783K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30,586 |
30,541 |
$773K |
| 88142 |
|
28,796 |
28,775 |
$772K |
| 87631 |
|
6,925 |
6,868 |
$763K |
| 80061 |
Lipid panel |
64,999 |
64,734 |
$757K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
29,173 |
29,007 |
$546K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
17,743 |
17,738 |
$529K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
68,465 |
65,752 |
$461K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
9,390 |
9,295 |
$394K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12,410 |
12,255 |
$371K |
| 86780 |
|
28,222 |
27,676 |
$332K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
40,597 |
38,487 |
$287K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
32,651 |
32,535 |
$273K |
| 82607 |
|
21,161 |
21,055 |
$270K |
| 86481 |
|
4,202 |
4,180 |
$226K |
| 85027 |
|
39,340 |
38,549 |
$222K |
| 86803 |
|
15,956 |
15,889 |
$199K |
| 86480 |
|
3,244 |
3,231 |
$173K |
| 84439 |
|
21,863 |
21,586 |
$172K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,569 |
23,635 |
$171K |
| 87634 |
|
3,123 |
3,104 |
$169K |
| 82728 |
|
13,237 |
13,083 |
$157K |
| 87081 |
|
26,400 |
26,049 |
$154K |
| 83970 |
|
4,223 |
4,179 |
$151K |
| 88342 |
|
1,321 |
1,266 |
$145K |
| 87506 |
|
739 |
736 |
$134K |
| 84702 |
|
9,944 |
7,550 |
$132K |
| 88304 |
|
1,727 |
1,652 |
$115K |
| 84403 |
|
4,825 |
4,760 |
$109K |
| 87340 |
|
11,518 |
11,455 |
$104K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,140 |
1,135 |
$97K |
| 82746 |
|
8,164 |
8,124 |
$96K |
| 83550 |
|
11,899 |
11,753 |
$90K |
| 88112 |
|
876 |
872 |
$84K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
5,281 |
5,271 |
$84K |
| 87186 |
|
10,694 |
10,174 |
$82K |
| 87505 |
|
749 |
743 |
$81K |
| 83655 |
|
7,423 |
7,342 |
$79K |
| 87070 |
|
9,727 |
9,489 |
$74K |
| 83540 |
|
12,852 |
12,693 |
$72K |
| 83013 |
|
1,175 |
1,173 |
$69K |
| 84402 |
|
3,119 |
3,102 |
$69K |
| 86706 |
|
7,047 |
7,024 |
$66K |
| 82670 |
|
2,660 |
2,578 |
$65K |
| 86003 |
|
1,776 |
1,373 |
$64K |
| 86038 |
|
6,052 |
6,032 |
$64K |
| 83001 |
|
3,901 |
3,859 |
$64K |
| 86762 |
|
7,369 |
7,339 |
$61K |
| 83880 |
|
2,193 |
2,115 |
$60K |
| 86235 |
|
2,491 |
1,797 |
$60K |
| 82570 |
|
15,651 |
15,254 |
$60K |
| 87077 |
|
7,537 |
6,905 |
$59K |
| 80076 |
|
8,391 |
8,092 |
$59K |
| 84146 |
|
3,407 |
3,383 |
$58K |
| 82043 |
|
11,545 |
11,503 |
$57K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,082 |
1,783 |
$56K |
| 83735 |
|
9,155 |
8,665 |
$53K |
| 86696 |
|
3,100 |
3,091 |
$52K |
| 84207 |
|
2,101 |
2,092 |
$51K |
| 87088 |
|
6,959 |
6,697 |
$51K |
| 81001 |
|
17,844 |
17,288 |
$49K |
| 84425 |
|
2,626 |
2,613 |
$48K |
| 84480 |
|
3,873 |
3,838 |
$48K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,215 |
823 |
$48K |
| 86140 |
|
12,955 |
12,475 |
$43K |
| 86704 |
|
3,949 |
3,932 |
$42K |
| 87536 |
|
557 |
552 |
$41K |
| 87147 |
|
8,767 |
8,644 |
$40K |
| 83520 |
|
3,406 |
3,346 |
$40K |
| 82784 |
|
3,406 |
3,017 |
$38K |
| 86850 |
|
5,923 |
5,879 |
$38K |
| 86160 |
|
2,451 |
1,794 |
$38K |
| 85652 |
|
15,894 |
15,383 |
$37K |
| 83002 |
|
2,287 |
2,240 |
$37K |
| 87522 |
Neg quan hep c or qual rna |
977 |
963 |
$36K |
| 88312 |
|
250 |
233 |
$36K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
69 |
69 |
$35K |
| 81508 |
|
997 |
989 |
$34K |
| 87150 |
|
1,040 |
1,033 |
$32K |
| 85610 |
|
8,836 |
6,746 |
$30K |
| 87529 |
|
946 |
468 |
$30K |
| 82533 |
|
1,883 |
1,633 |
$28K |
| 86376 |
|
2,214 |
2,203 |
$28K |
| 82105 |
|
1,941 |
1,928 |
$28K |
| 86141 |
|
2,418 |
2,401 |
$27K |
| 86787 |
|
3,255 |
3,238 |
$27K |
| 84153 |
|
1,656 |
1,640 |
$26K |
| 86225 |
|
2,143 |
2,107 |
$26K |
| 84144 |
|
1,414 |
1,262 |
$26K |
| 86200 |
|
2,261 |
2,252 |
$26K |
| 81511 |
|
264 |
264 |
$25K |
| 84255 |
|
1,096 |
1,094 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
484 |
478 |
$24K |
| 82525 |
|
2,221 |
2,198 |
$24K |
| 83690 |
|
4,203 |
4,131 |
$24K |
| 86765 |
|
2,826 |
2,812 |
$23K |
| 82627 |
|
1,119 |
1,114 |
$22K |
| 88341 |
|
120 |
103 |
$21K |
| 86735 |
|
2,545 |
2,528 |
$21K |
| 86431 |
|
4,182 |
4,168 |
$21K |
| 80069 |
|
2,775 |
2,497 |
$21K |
| 86708 |
|
1,874 |
1,866 |
$20K |
| 84446 |
|
1,631 |
1,624 |
$20K |
| 86618 |
|
2,333 |
2,318 |
$20K |
| 83516 |
|
1,586 |
1,533 |
$20K |
| 84681 |
|
1,082 |
1,080 |
$20K |
| 87338 |
|
1,553 |
1,551 |
$20K |
| 84630 |
|
2,259 |
2,251 |
$19K |
| 83993 |
|
1,160 |
1,149 |
$19K |
| 87252 |
|
846 |
841 |
$19K |
| 84590 |
|
1,872 |
1,860 |
$19K |
| 84597 |
|
1,576 |
1,568 |
$19K |
| 83020 |
|
1,657 |
1,654 |
$19K |
| 86364 |
|
2,546 |
2,539 |
$18K |
| 82950 |
|
4,515 |
4,499 |
$17K |
| 86695 |
|
2,125 |
2,118 |
$17K |
| 86665 |
|
1,362 |
946 |
$16K |
| 86800 |
|
1,485 |
1,478 |
$16K |
| 86901 |
|
6,097 |
6,051 |
$16K |
| 86900 |
|
6,066 |
6,019 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
497 |
492 |
$15K |
| 83921 |
|
1,067 |
1,064 |
$15K |
| 82785 |
|
1,046 |
1,043 |
$15K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,384 |
1,383 |
$15K |
| 84481 |
|
1,008 |
1,006 |
$15K |
| 84550 |
|
3,804 |
3,739 |
$15K |
| 84156 |
|
4,584 |
4,251 |
$15K |
| 84703 |
|
2,159 |
2,125 |
$14K |
| 83525 |
|
1,403 |
1,385 |
$14K |
| 82150 |
|
2,471 |
2,440 |
$14K |
| 82550 |
|
2,385 |
2,294 |
$14K |
| 83721 |
|
1,632 |
1,623 |
$13K |
| 87272 |
|
1,278 |
1,246 |
$13K |
| 85730 |
|
2,390 |
2,356 |
$13K |
| 84460 |
|
2,715 |
2,674 |
$12K |
| 86039 |
|
1,219 |
1,212 |
$12K |
| 80074 |
|
290 |
290 |
$12K |
| 83615 |
|
2,075 |
1,875 |
$11K |
| 88184 |
|
150 |
150 |
$11K |
| 84450 |
|
2,352 |
2,314 |
$11K |
| 84165 |
|
1,135 |
1,112 |
$11K |
| 81003 |
|
5,303 |
5,269 |
$10K |
| 86360 |
|
254 |
252 |
$10K |
| 82248 |
|
2,331 |
2,202 |
$10K |
| 87102 |
|
1,280 |
1,214 |
$10K |
| 83090 |
|
670 |
670 |
$10K |
| 87255 |
|
330 |
326 |
$10K |
| 86147 |
|
560 |
373 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
96 |
96 |
$10K |
| 87449 |
|
867 |
860 |
$9K |
| 82565 |
|
1,898 |
1,880 |
$8K |
| 87253 |
|
546 |
546 |
$8K |
| 83014 |
|
1,190 |
1,186 |
$8K |
| 84100 |
|
1,911 |
1,766 |
$8K |
| 82951 |
|
775 |
772 |
$8K |
| 82977 |
|
1,252 |
1,178 |
$8K |
| 80050 |
General health panel |
268 |
263 |
$7K |
| 82465 |
|
1,828 |
1,798 |
$7K |
| 82947 |
|
2,020 |
2,010 |
$7K |
| 85014 |
|
3,330 |
3,310 |
$7K |
| 83498 |
|
287 |
286 |
$7K |
| 87269 |
|
666 |
653 |
$7K |
| 86146 |
|
388 |
252 |
$7K |
| 84163 |
|
500 |
497 |
$7K |
| 87209 |
|
374 |
215 |
$6K |
| 83021 |
|
394 |
393 |
$6K |
| 84478 |
|
1,209 |
1,062 |
$6K |
| 82247 |
|
1,313 |
977 |
$6K |
| 85018 |
|
2,672 |
2,614 |
$6K |
| 86359 |
|
167 |
165 |
$5K |
| 99001 |
|
752 |
749 |
$5K |
| 80164 |
|
440 |
427 |
$5K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
69 |
60 |
$5K |
| 80178 |
|
851 |
799 |
$5K |
| 81025 |
|
797 |
779 |
$4K |
| 87493 |
|
142 |
141 |
$4K |
| 84152 |
|
273 |
273 |
$4K |
| 85045 |
|
1,136 |
1,095 |
$4K |
| 85379 |
|
443 |
434 |
$4K |
| 84445 |
|
148 |
148 |
$4K |
| 86308 |
|
800 |
796 |
$4K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
355 |
207 |
$3K |
| 82330 |
|
285 |
278 |
$3K |
| 87101 |
|
489 |
483 |
$3K |
| 87324 |
|
332 |
330 |
$3K |
| 85613 |
|
385 |
383 |
$3K |
| 82310 |
|
717 |
685 |
$3K |
| 82088 |
|
88 |
86 |
$3K |
| 82103 |
|
267 |
264 |
$3K |
| 82390 |
|
358 |
356 |
$3K |
| 84466 |
|
262 |
262 |
$3K |
| 82952 |
|
777 |
766 |
$3K |
| 86015 |
|
377 |
376 |
$3K |
| 85240 |
|
163 |
162 |
$3K |
| 85246 |
|
118 |
117 |
$2K |
| 85245 |
|
118 |
117 |
$2K |
| 86317 |
|
26 |
13 |
$2K |
| 84155 |
|
686 |
682 |
$2K |
| 82677 |
|
112 |
112 |
$2K |
| 87106 |
|
336 |
320 |
$2K |
| 87177 |
|
234 |
224 |
$2K |
| 87641 |
|
60 |
60 |
$2K |
| 84436 |
|
301 |
299 |
$2K |
| 85049 |
|
459 |
459 |
$2K |
| 86336 |
|
125 |
125 |
$2K |
| 86334 |
|
87 |
87 |
$2K |
| 86705 |
|
163 |
163 |
$2K |
| 83630 |
|
97 |
97 |
$2K |
| 84132 |
|
394 |
389 |
$2K |
| 86036 |
|
190 |
188 |
$1K |
| 82166 |
|
56 |
56 |
$1K |
| 84520 |
|
383 |
381 |
$1K |
| 84075 |
|
281 |
275 |
$1K |
| 82040 |
|
283 |
280 |
$1K |
| 84244 |
|
62 |
61 |
$1K |
| 86617 |
|
78 |
35 |
$1K |
| 82653 |
|
65 |
65 |
$935.35 |
| 86255 |
|
84 |
84 |
$913.32 |
| 87075 |
|
115 |
111 |
$861.47 |
| 83695 |
|
76 |
76 |
$855.75 |
| 86709 |
|
87 |
86 |
$841.20 |
| 86304 |
|
44 |
40 |
$806.96 |
| 87205 |
|
240 |
230 |
$656.90 |
| 87206 |
|
126 |
108 |
$652.74 |
| 82378 |
|
42 |
41 |
$640.18 |
| 81050 |
|
242 |
240 |
$632.80 |
| 84295 |
|
142 |
140 |
$593.60 |
| 83835 |
|
38 |
36 |
$582.27 |
| 86694 |
|
68 |
68 |
$565.76 |
| 83521 |
|
52 |
24 |
$562.64 |
| 84305 |
|
31 |
31 |
$499.10 |
| 87517 |
|
13 |
12 |
$490.75 |
| 82374 |
|
106 |
105 |
$448.24 |
| 84432 |
|
63 |
62 |
$440.28 |
| 82435 |
|
107 |
106 |
$425.25 |
| 84134 |
|
27 |
25 |
$334.10 |
| 0077U |
|
12 |
12 |
$326.40 |
| 86060 |
|
53 |
53 |
$321.18 |
| 82272 |
|
109 |
108 |
$312.83 |
| 86305 |
|
16 |
13 |
$293.44 |
| 80051 |
|
50 |
50 |
$281.50 |
| 87140 |
|
50 |
50 |
$255.32 |
| 87040 |
|
27 |
25 |
$254.80 |
| 84270 |
|
13 |
12 |
$248.95 |
| 86592 |
|
92 |
89 |
$233.68 |
| 86645 |
|
27 |
26 |
$232.47 |
| 83789 |
|
12 |
12 |
$190.92 |
| 84166 |
|
14 |
12 |
$179.34 |
| 87107 |
|
27 |
27 |
$173.44 |
| 80306 |
|
12 |
12 |
$153.72 |
| 82610 |
|
13 |
12 |
$130.13 |
| 86644 |
|
12 |
12 |
$99.84 |
| 85384 |
|
12 |
12 |
$89.76 |
| 80047 |
|
12 |
12 |
$77.66 |
| 82340 |
|
12 |
12 |
$63.84 |
| 85660 |
|
12 |
12 |
$58.32 |
| 36415 |
Collection of venous blood by venipuncture |
1,173 |
1,099 |
$0.00 |